Top

Published in:

01-12-2020 | Osteoporosis | Original Article

Fractures in patients with rheumatoid arthritis and end-stage renal disease

Authors: Renée Peterkin-McCalman, Jennifer L. Waller, Brian Le, Alyce M. Oliver, Evan Manning, Rachel E. Elam, Mufaddal Kheda, Norris Stanley Nahman Jr, Laura D. Carbone

Published in: Archives of Osteoporosis | Issue 1/2020

Abstract

Summary

Having rheumatoid arthritis (RA) or end-stage renal disease (ESRD) can lead to fractures. RA independently increases the risk of hip or other femur fracture in dialysis patients. Use of corticosteroids is a potentially modifiable risk factor for fractures among persons with RA and ESRD on dialysis.

Purpose

Rheumatoid arthritis (RA) and end-stage renal disease (ESRD) both independently increase fracture risk; however, how RA and ESRD interplay to affect fracture risk is unknown. We aim to determine the association of RA with fracture in ESRD and identify risk factors for fracture in patients with RA and ESRD.

Methods

A retrospective cohort study was conducted using the United States Renal Data System (USRDS) to identify ESRD adults with and without a history of RA who initiated dialysis in 2005–2008. International Classification of Diseases, 9th Revision (ICD-9) codes were used to identify fractures following start of dialysis. Risk for incident fracture was compared between those with and without RA. Potential risk factors for fracture among persons with RA and ESRD were analyzed.

Results

There were 754 persons with ESRD and RA, of whom 126 (17%) had any incident fracture. In multivariable adjusted final models, among ESRD patients, RA was an independent risk factor for hip/femur fracture (RR 1.28, 95% CI 1.01–1.64). Among persons with RA and ESRD, in final models, only corticosteroid use was a significant risk factor for both any incident (RR 2.00, 95% CI 1.40–2.87) and hip/femur (RR 1.97, 95% CI 1.24–3.11) fracture. Those with higher body mass index had a lower relative risk of hip/femur fracture (RR 0.95, 95% CI 0.91–0.99).

Conclusion

Among ESRD patients, those with RA have a 28% increased risk for hip or other femur fracture. Use of corticosteroids is a potentially modifiable risk factor for fractures among persons with RA and ESRD.

Kim D, Cho SK, Choi CB, Jun JB, Kim TH, Lee HS, Lee J, Lee SS, Yoo DH, Yoo WH, Sung YK, Bae SC (2016) Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study. Rheumatol Int 36(9):1205–1214. https://doi.org/10.1007/s00296-016-3453-zCrossRefPubMed

Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R (2001) Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 60(5):521–522. https://doi.org/10.1136/ard.60.5.521CrossRefPubMedPubMedCentral

Lin YC, Li YH, Chang CH, Hu CC, Chen DW, Hsieh PH, Lee MS, Ueng SW, Chang Y (2015) Rheumatoid arthritis patients with hip fracture: a nationwide study. Osteoporos Int 26(2):811–817. https://doi.org/10.1007/s00198-014-2968-yCrossRefPubMed

Heinlen L, Humphrey MB (2017) Skeletal complications of rheumatoid arthritis. Osteoporos Int 28(10):2801–2812. https://doi.org/10.1007/s00198-017-4170-5CrossRefPubMed

Miller PD (2014) Bone disease in CKD: a focus on osteoporosis diagnosis and management. Am J Kidney Dis 64(2):290–304. https://doi.org/10.1053/j.ajkd.2013.12.018CrossRefPubMed

Gibofsky A (2014) Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis. Am J Manag Care 20(7 Suppl):S128–S135PubMed

Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, Solomon DH (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12(4):R154. https://doi.org/10.1186/ar3107CrossRefPubMedPubMedCentral

Brennan SL, Toomey L, Kotowicz MA, Henry MJ, Griffiths H, Pasco JA (2014) Rheumatoid arthritis and incident fracture in women: a case–control study. BMC Musculoskelet Disord 15:13. https://doi.org/10.1186/1471-2474-15-13CrossRefPubMedPubMedCentral

Lin ZZ, Wang JJ, Chung CR, Huang PC, Su BA, Cheng KC, Chio CC, Chien CC (2014) Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study. Bone 64:235–239. https://doi.org/10.1016/j.bone.2014.04.017CrossRefPubMed

10.

Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58(1):396–399. https://doi.org/10.1046/j.1523-1755.2000.00178.xCrossRefPubMed

11.

Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK (2019) Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial. Jama 322(8):736–745. https://doi.org/10.1001/jama.2019.11889CrossRefPubMedPubMedCentral

12.

Paudyal S, Yang FM, Rice C, Chen CC, Skelton M, Bethel M, Brown S, Nahman NS Jr, Carbone L (2017) End-stage renal disease in patients with rheumatoid arthritis. Semin Arthritis Rheum 46(4):418–422. https://doi.org/10.1016/j.semarthrit.2016.07.016CrossRefPubMed

13.

Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB (2017) Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int 37(9):1551–1557. https://doi.org/10.1007/s00296-017-3726-1CrossRefPubMed

14.

Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, Gu H, Hirth RA, Hutton D, Jin Y, Kapke A, Kurtz V, Li Y, McCullough K, Modi Z, Morgenstern H, Mukhopadhyay P, Pearson J, Pisoni R, Repeck K, Schaubel DE, Shamraj R, Steffick D, Turf M, Woodside KJ, Xiang J, Yin M, Zhang X, Shahinian V (2020) US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 75(1 Suppl 1):A6–A7. https://doi.org/10.1053/j.ajkd.2019.09.003CrossRefPubMed

15.

McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219. https://doi.org/10.1056/NEJMra1004965CrossRefPubMed

16.

Mullen MB, Saag KG (2015) Evaluating and mitigating fracture risk in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 29(4-5):614–627. https://doi.org/10.1016/j.berh.2015.09.005CrossRefPubMed

17.

Arneson TJ, Li S, Liu J, Kilpatrick RD, Newsome BB, St Peter WL (2013) Trends in hip fracture rates in US hemodialysis patients, 1993–2010. Am J Kidney Dis 62(4):747–754. https://doi.org/10.1053/j.ajkd.2013.02.368CrossRefPubMed

18.

Foley RN, Collins AJ (2013) The USRDS: what you need to know about what it can and can’t tell us about ESRD. Clin J Am Soc Nephrol 8(5):845–851. https://doi.org/10.2215/cjn.06840712CrossRefPubMed

19.

Altindag O, Erel O, Soran N, Celik H, Selek S (2008) Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 28(4):317–321CrossRef

20.

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049CrossRef

21.

Aluoch AO, Jessee R, Habal H, Garcia-Rosell M, Shah R, Reed G, Carbone L (2012) Heart failure as a risk factor for osteoporosis and fractures. Curr Osteoporos Rep 10(4):258–269. https://doi.org/10.1007/s11914-012-0115-2CrossRefPubMed

22.

Rigler SK, Ellerbeck E, Whittle J, Mahnken J, Cook-Wiens G, Shireman TI (2011) Comparing methods to identify hip fracture in a nursing home population using Medicare claims. Osteoporos Int 22(1):57–61. https://doi.org/10.1007/s00198-010-1264-8CrossRefPubMed

23.

Le B, Waller JL, Radhakrishnan R, Oh SJ, Kheda MF, Nahman NS Jr, Carbone L (2018) Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease. Lupus 27(1):17–24. https://doi.org/10.1177/0961203317709953CrossRefPubMed

24.

Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O’Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27(11):3239–3249. https://doi.org/10.1007/s00198-016-3646-zCrossRefPubMed

25.

Pan W (2001) Akaike’s information criterion in generalized estimating equations. Biometrics 57(1):120–125CrossRef

26.

Mittalhenkle A, Gillen DL, Stehman-Breen CO (2004) Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44(4):672–679CrossRef

27.

Briot K, Geusens P, Em Bultink I, Lems WF, Roux C (2017) Inflammatory diseases and bone fragility. Osteoporos Int 28(12):3301–3314. https://doi.org/10.1007/s00198-017-4189-7CrossRefPubMed

28.

Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford, England) 53(10):1759–1766. https://doi.org/10.1093/rheumatology/keu162CrossRef

29.

Roussy JP, Bessette L, Bernatsky S, Rahme E, Lachaine J (2013) Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over. Osteoporos Int 24(9):2483–2492. https://doi.org/10.1007/s00198-013-2321-xCrossRefPubMed

30.

van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13(10):777–787. https://doi.org/10.1007/s001980200108CrossRefPubMed

31.

Office of the Surgeon General (US) (2004) Bone health and osteoporosis: a report of the surgeon general. Office of the Surgeon General (US), Rockville

32.

Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14(9):1622–1627. https://doi.org/10.1359/jbmr.1999.14.9.1622CrossRefPubMed

33.

Crandall CJ, Yildiz VO, Wactawski-Wende J, Johnson KC, Chen Z, Going SB, Wright NC, Cauley JA (2015) Postmenopausal weight change and incidence of fracture: post hoc findings from Women's Health Initiative Observational Study and Clinical Trials. BMJ 350:h25 Published 2015 Jan 27. https://doi.org/10.1136/bmj.h25CrossRefPubMedPubMedCentral

34.

Meyer HE, Tverdal A, Selmer R (1998) Weight variability, weight change and the incidence of hip fracture: a prospective study of 39,000 middle-aged Norwegians. Osteoporos Int 8(4):373–378. https://doi.org/10.1007/s001980050077CrossRefPubMed

35.

Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15(4):155–160. https://doi.org/10.1097/RHU.0b013e3181a5679dCrossRefPubMed

36.

Phuan-Udom R, Lektrakul N, Katchamart W (2018) The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis. Clin Rheumatol 37(10):2603–2610. https://doi.org/10.1007/s10067-018-4218-8CrossRefPubMed

37.

van Onna M, Boonen A (2016) The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord 17:184. https://doi.org/10.1186/s12891-016-1038-3CrossRefPubMedPubMedCentral

38.

Abramowitz MK, Hall CB, Amodu A, Sharma D, Androga L, Hawkins M (2018) Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study [published correction appears in PLoS One. 2018 May 24;13(5):e0198318]. PLoS One 13(4):e0194697. Published 2018 Apr 11. https://doi.org/10.1371/journal.pone.0194697CrossRefPubMedPubMedCentral

39.

Al-Badr W, Martin KJ (2008) Vitamin D and kidney disease. Clin J Am Soc Nephrol 3(5):1555–1560. https://doi.org/10.2215/cjn.01150308CrossRefPubMedPubMedCentral

40.

Chen YJ, Kung PT, Wang YH, Huang CC, Hsu SC, Tsai WC, Hsu HC (2014) Greater risk of hip fracture in hemodialysis than in peritoneal dialysis. Osteoporos Int 25(5):1513–1518. https://doi.org/10.1007/s00198-014-2632-6CrossRefPubMed

41.

Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK, Black DM, Ensrud KE, Fracture Intervention Trial Research Group (2005) What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res 20(7):1216–1222. https://doi.org/10.1359/JBMR.050314CrossRefPubMed

Title: Fractures in patients with rheumatoid arthritis and end-stage renal disease
Authors: Renée Peterkin-McCalman
Jennifer L. Waller
Brian Le
Alyce M. Oliver
Evan Manning
Rachel E. Elam
Mufaddal Kheda
Norris Stanley Nahman Jr
Laura D. Carbone
Publication date: 01-12-2020
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Rheumatoid Arthritis
Published in: Archives of Osteoporosis / Issue 1/2020
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-020-00815-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Fractures in patients with rheumatoid arthritis and end-stage renal disease

Abstract

Summary

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model

Response regarding the importance of vitamin D and calcium among undergraduate health sciences students in Al Kharj, Saudi Arabia

A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates

‘Nonagenarians’ with a hip fracture: is a different orthogeriatric treatment strategy necessary?

Bone mineral density among Palestinian patients suffering from hemoglobinopathy disorders